Ownership history in B Group, Inc. · 5 quarters on record
This page tracks every 13F SEC filing in which B Group, Inc. reported a position in IOVANCE BIOTHERAPEUTICS INC (IOVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,500,000 | — | 0% | 3.02% | $4.1M | $2.73 |
| 2025 Q3 | UNCHANGED | 1,500,000 | — | 0% | 2.39% | $3.3M | $2.17 |
| 2025 Q2 | UNCHANGED | 1,500,000 | — | 0% | 1.99% | $2.6M | $1.72 |
| 2025 Q1 | ADDED | 1,500,000 | +508,000 | +51.2% | 4.28% | $5.0M | $3.33 |
| 2024 Q4 | INITIATED | 992,000 | — | — | 4.49% | $7.3M | $7.40 |
As of 2025 Q4 — sorted by position size